skip to main content
LOTERRE

LOTERRE

Chemical Entities of Biological Interest Ontology (CHEBI)

Search from vocabulary

Content language

| español français
Search help

Concept information

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > azamacrocycle > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > lactam > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carboxamide > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carboxamide > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carboxamide > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > carboxamide > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > cyclic amide > lactam > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ether > aromatic ether > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ether > aromatic ether > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ether > aromatic ether > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > aromatic compound > organic aromatic compound > aromatic ether > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > aromatic ether > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > aromatic ether > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > aromatic ether > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > aromatic amide > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > aromatic compound > organic aromatic compound > aromatic amide > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > aromatic amide > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > aromatic amide > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > aromatic amide > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > secondary amide > imide > mixed diacylamine > N-sulfonylcarboxamide > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrazines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > carbocyclic compound > cyclopropanes > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > carbocyclic compound > cyclopropanes > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > carbocyclic compound > cyclopropanes > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > homocyclic compound > carbocyclic compound > cyclopropanes > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteropolycyclic compound > heterotricyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > heteropolycyclic compound > heterotricyclic compound > organic heterotricyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > dibenzopyridine > phenanthridines > paritaprevir
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > dibenzopyridine > phenanthridines > paritaprevir

Preferred term

paritaprevir  

Broader concept(s)

Synonym(s)

  • (2R,6S,12Z,13aR,14aR,16aS)-N-(cyclopropanesulfonyl)-6-[(5-methylpyrazine-2-carbonyl)amino]-5,16-dioxo-2-[(phenanthridin-6-yl)oxy]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide

Belongs to group

URI

http://data.loterre.fr/ark:/67375/KFP-CTS6S7HN-G

Download this concept:

RDF/XML TURTLE JSON-LD Last modified 3/25/22